Exponent Inc (EXPO) stock
Close on Nov 17, 2026Market cap $4.17BP/E 39.3Yield 1.37%
Earnings
Exponent's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of Exponent's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Source |
|---|---|---|---|---|---|
| Q4 FY2026ended Jan 2, 2027 | Feb 4, 2027Expected | – | – | – | – |
| Q3 FY2026ended Oct 2, 2026 | Oct 29, 2026after the close | $173.70M | +18.1% | $0.64 | Release |
| Q2 FY2026ended Jul 3, 2026 | Jul 30, 2026during market hours | $171.60M | +20.8% | $0.60 | Release |
| Q1 FY2026ended Apr 3, 2026 | Apr 30, 2026during market hours | $166.30M | +14.3% | $0.59 | Release |
| Q4 FY2025ended Jan 2, 2026 | Feb 5, 2026during market hours | $147.40M | +7.7% | $0.49 | Release |
| Q3 FY2025ended Oct 3, 2025 | Oct 30, 2025during market hours | $147.10M | +7.9% | $0.55 | Release |
| Q2 FY2025ended Jul 4, 2025 | Jul 31, 2025during market hours | $142.00M | +1.1% | $0.52 | Release |
| Q1 FY2025ended Apr 4, 2025 | May 1, 2025during market hours | $145.50M | +0.4% | $0.52 | Release |
| Q4 FY2024ended Jan 3, 2025 | Feb 6, 2025during market hours | $136.80M | +11.3% | $0.46 | Release |
| Q3 FY2024ended Sep 27, 2024 | Oct 24, 2024during market hours | $136.30M | +2.3% | $0.50 | Release |
| Q2 FY2024ended Jun 28, 2024 | Jul 25, 2024during market hours | $140.50M | +0.2% | $0.57 | Release |
| Q1 FY2024ended Mar 29, 2024 | Apr 25, 2024during market hours | $144.90M | +3.3% | $0.59 | Release |
| Q4 FY2023ended Dec 29, 2023 | Feb 1, 2024during market hours | $122.90M | -3.5% | $0.41 | Release |
| Q3 FY2023ended Sep 29, 2023 | Oct 26, 2023during market hours | $133.30M | +4.8% | $0.48 | Release |
| Q2 FY2023ended Jun 30, 2023 | Jul 27, 2023during market hours | $140.20M | +7.6% | $0.50 | Release |
| Q1 FY2023ended Mar 31, 2023 | Apr 27, 2023during market hours | $140.30M | +9.2% | $0.56 | Release |
| Q4 FY2022ended Dec 30, 2022 | Feb 2, 2023during market hours | $127.40M | +12.2% | $0.44 | Release |
| Q3 FY2022ended Sep 30, 2022 | Oct 27, 2022during market hours | $127.20M | +9.3% | $0.47 | Release |
| Q2 FY2022ended Jul 1, 2022 | Jul 28, 2022during market hours | $130.30M | – | $0.49 | Release |
| Q1 FY2022ended Apr 1, 2022 | Apr 28, 2022during market hours | $128.50M | – | $0.56 | Release |
| Q4 FY2021ended Dec 31, 2021 | Feb 3, 2022during market hours | $113.50M | – | $0.38 | Release |
| Q3 FY2021ended Oct 1, 2021 | Oct 28, 2021during market hours | $116.40M | – | $0.46 | Release |
| Q2 FY2021ended Jul 2, 2021 | Jul 29, 2021during market hours | – | – | – | Release |
| Q1 FY2021ended Apr 2, 2021 | Apr 29, 2021during market hours | – | – | – | Release |
| Q4 FY2020ended Jan 1, 2021 | Feb 4, 2021during market hours | – | – | – | Release |
| Q3 FY2020ended Oct 2, 2020 | Oct 29, 2020during market hours | – | – | – | Release |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
Exponent's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| Revenues before reimbursements | Q4 FY2026 | +8% – +10% | – | New | Oct 29, 2026 |
| EBITDAnon-GAAP | Q4 FY2026 | 26.3% – 26.8% | – | New | Oct 29, 2026 |
| Revenues before reimbursements | FY2026 | +10% – +11% | – | New | Oct 29, 2026 |
| Revenues before reimbursementsnon-GAAP | FY2026 | +9% – +10% | – | New | Jul 30, 2026 |
| EBITDAnon-GAAP | FY2026 | 28% – 28.3% | – | New | Oct 29, 2026 |
| EBITDA 1 to be 27.8% to 28.1% of revenues before reimbursementsnon-GAAP | FY2026 | 27.8% – 28.1% | 27.6% – 28.1% | Raised | Jul 30, 2026 |
Guidance vs results
The last range Exponent gave before each report, against the figure it then reported. Full years add up the four quarters.
| Period | Metric | Guidance | Actual | Result |
|---|---|---|---|---|
| Q3 FY2026 | Revenue growth | +8% – +10% | +18.08% | Above range |
Guidance history
Every forecast Exponent put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Oct 29, 2026 | EBITDA | FY2026 | 28% – 28.3% | New |
| Oct 29, 2026 | EBITDA | Q4 FY2026 | 26.3% – 26.8% | New |
| Oct 29, 2026 | Revenues before reimbursements | FY2026 | +10% – +11% | New |
| Oct 29, 2026 | Revenues before reimbursements | Q4 FY2026 | +8% – +10% | New |
| Jul 30, 2026 | EBITDA 1 to be 27.8% to 28.1% of revenues before reimbursements | FY2026 | 27.8% – 28.1% | Raised |
| Jul 30, 2026 | EBITDA 1 to be 28.0% to 28.5% of revenues before reimbursements | Q3 FY2026 | 28% – 28.5% | New |
| Jul 30, 2026 | Revenues before reimbursements | Q3 FY2026 | +8% – +10% | New |
| Jul 30, 2026 | Revenues before reimbursements | FY2026 | +9% – +10% | New |
| Apr 30, 2026 | EBITDA 1 to be % of revenues before reimbursements | Q2 FY2026 | 27% – 27.8% | New |
| Apr 30, 2026 | EBITDA 1 to be % of revenues before reimbursements | FY2026 | 27.6% – 28.1% | Reaffirmed |
| Feb 5, 2026 | EBITDA | Q1 FY2026 | 27.5% – 28.5% | New |
| Feb 5, 2026 | EBITDA | FY2026 | 27.6% – 28.1% | New |
| Oct 30, 2025 | EBITDA 1 as a percentage of revenues before reimbursements | Q4 FY2025 | 26% – 27% | New |
| Oct 30, 2025 | EBITDA 1 as a percentage of revenues before reimbursements | FY2025 | 27.4% – 27.65% | New |
| Jul 31, 2025 | EBITDA | FY2025 | 26.5% – 27% | Raised |
| Jul 31, 2025 | EBITDA | Q3 FY2025 | 26.75% – 27.75% | New |
| May 1, 2025 | EBITDA | FY2025 | 26.25% – 27% | Reaffirmed |
| May 1, 2025 | EBITDA | Q2 FY2025 | 26% – 27% | New |
| Feb 6, 2025 | EBITDA 1 to be | FY2025 | 26.25% – 27% | New |
| Feb 6, 2025 | EBITDA 1 to be | Q1 FY2025 | 25% – 26% | New |
| Oct 24, 2024 | EBITDA as a percentage of revenues before reimbursements | FY2024 | 27.9% – 28.1% | New |
| Oct 24, 2024 | EBITDA as a percentage of revenues before reimbursements | Q4 FY2024 | 23.5% – 24.5% | New |
| Jul 25, 2024 | EBITDA | FY2024 | 27.5% – 28% | Raised |
| Jul 25, 2024 | EBITDA | Q3 FY2024 | 26.75% – 27.5% | New |
| Apr 25, 2024 | EBITDA | FY2024 | 26.25% – 27% | Raised |
| Apr 25, 2024 | EBITDA | Q2 FY2024 | 27.25% – 28.25% | New |
| Feb 1, 2024 | EBITDA | FY2024 | 25.75% – 26.5% | New |
| Feb 1, 2024 | EBITDA | Q1 FY2024 | 26% – 27% | New |
| Oct 26, 2023 | EBITDA | FY2023 | 27.4% – 27.8% | Lowered |
| Oct 26, 2023 | EBITDA | Q4 FY2023 | 26% – 27% | New |
| Jul 27, 2023 | EBITDA | FY2023 | 28% – 28.5% | Reaffirmed |
| Jul 27, 2023 | EBITDA | Q3 FY2023 | 27.5% – 28.5% | New |
| Apr 27, 2023 | EBITDA | FY2023 | 28% – 28.5% | Reaffirmed |
| Apr 27, 2023 | EBITDA | Q2 FY2023 | 27.5% – 28.5% | New |
| Feb 2, 2023 | EBITDA | FY2023 | 28% – 28.5% | New |
| Feb 2, 2023 | EBITDA | Q1 FY2023 | 27.5% – 28.2% | New |
| Oct 27, 2022 | Revenues before reimbursements | FY2022 | +6% – +7% | New |
| Jul 28, 2022 | EBITDA 1 margin | FY2022 | 150 – 200 | New |
| Jul 28, 2022 | EBITDA 1 margin | Q3 FY2022 | 300 – 375 | New |
| Oct 28, 2021 | EBITDA 1 margin | Q4 FY2021 | 175 – 225 | New |
| Oct 28, 2021 | EBITDA 1 margin | FY2021 | 290 – 310 | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Exponent filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
See a number that looks wrong?